This application relates to the field of medical technology and to a new application of a fragrance regenerative pill in the preparation of medicines for heart failure. The inventor patent technologist has discovered new uses of vasectomy, i. E., improved cytophysical abnormalities, corrected t-wave lifts, and regulated heart rhythms; improved cardiac function, increased blood fractions and shorter axes of the left heart; constricted exterior arteries and reduced cardiac loads; and suggested that vasectomy had an anti-heart failure effect。
Download all detailed technical information
[summary of technical realization steps]
This application concerns medicine and a new application for a vasectomy to prepare for heart failure。
Technical presentation
1. Heart failure (heart failure, hf) is a complex set of clinical syndromes caused by abnormal changes in heart structure and/or function, constriction and/or constriction of the heart for a variety of reasons, mainly manifested in respiratory difficulties, fatigue and fluid ailments (pulmonary silt, cyclic silt and external oedema) and a severe and terminal phase of most physical heart disease。
2. At present, heart failure treatment is targeted primarily to improve heart function, reduce symptoms and improve prognosis, and drug treatment strategies include, inter alia, increased heart output, reduced heart loads and improved myocardial myocardial re-organisation, with clinical use of urea, renal-vascular nervous system (ras) inhibitors, beta receptor retardants and salt cortex receptors. The improvement in the post-treatment combination of drugs such as antigens (mra) and left-cardial blood fractions (ef) is an important indicator for assessing the effectiveness of heart failure treatment. While current treatments have significantly improved patient expectations, the rates of heart failure and death remain high, and heart failure has become a major public health problem. In view of this, it is necessary to explore new anti-heart failure options。
Technical realization thinking
1. One or more examples of the implementation of the present application provide an application for the preparation of anti-cardial decay drugs. Package
Technical protection points
1. Use of vasectomy in the production of anti-cardial decay drugs。
2. The application described in claim 1 is characterized by the improvement of the ekv of the drug in question。
3. The application described in claim 2 is characterized by a reduction in the t-wave height or/or an increase in the heart rate。
4. The application described in claim 1 is characterized by abnormalities in the improvement of heart constriction function。
5. The application described in claim 4 is characterized by an increase in the left-cardial blood fraction or/or reduction rate。
6. The application described in claim 1 is characterized by a constriction of the medication。
7. The application described in claim 6 is characterized by an vascular contraction induced by pe-inducing of the drug in question。
8. Rights
Technical profile summary
1. Use of vasectomy in the production of anti-cardial decay drugs。
2. The application described in claim 1 is characterized by the improvement of the ekv of the drug in question。
3. The application described in claim 2 is characterized by a reduction in the t-wave height or/or a resonance rate。
4. The application described in claim 1 is characterized by abnormalities in the improvement of heart constriction function。
5. The application described in claim 4 is characterized by an increase in the left-cardial blood fraction or/or reduction rate。
[property technical properties]
Technical researcher: wang nannan, pendant, chen wei jie, zheng ming choi, yang tsing, wu yaping, wong autumn, nina
Applicant (patent): guangzhou baek yunsan wonder pharmaceuticals ltd
Type: invention
Country and city:
I'm the owner of this patent
